Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |